Other · 27 Feb 2021
OtherPublished 5 May 2021
A Cure to Illness
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer, which are being investigated).
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2020
Phase IIb/III Studies in the cure of (AZEE Vaccine) in the COVID-19 with Co-morbid illness Patients
Conference abstract · 8 Mar 2018
Discovering of a reverse pathway in lymphocytes will change not only random theory of immune globulin synthesis and the central dogma of molecular biology, also will bring a novel super-antibody (sab) technology for very effective and fast treatment and cure of all of infectious diseases and cancer!
Editorial · 31 Aug 2021
Treatment and curing of vascular illness in humans
Other · 2020
A Cure to Illness on Ethical Issues World Vaccine Meet 2020
More from this journal
The newest in Journal of Immune Disorders & Therapy.
Research article · 31 Jul 2023
Retrospective evaluation of efficacy in cytokine storm management among critically ill COVID-19 patients
Conference abstract · 7 Oct 2022
TGF-Beta in Chagas disease development: Molecular insights, antifibrotic effects and, clinical utility
Conference abstract · 7 Oct 2022
Soluble Urokinase Receptor as a promising marker for early prediction of outcome in COVID-19 hospitalized patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Immune Disorders & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Arije Ghannam”

